Physician profile
Maryam Ahmadian
NPI 1811909955
$3,245.93
in general payments reported to CMS, 2019-2025
20 companies · $679 in 2025
The $679 reported for 2025 was more than what 98% of Licensed Practical Nurse providers received nationally (typical 2025 total: $38.94).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $433 · 2022: $627 · 2023: $604 · 2024: $903 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $422.74 | 2023-2024 | Dovato |
| Incyte Corporation | $368.50 | 2021-2025 | Opzelura |
| Gilead Sciences, INC. | $321.85 | 2021-2025 | |
| Abbvie INC. | $311.71 | 2021-2025 | |
| Lilly USA, LLC | $263.81 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $225.78 | 2022-2025 | |
| Dermavant Sciences, INC. | $217.16 | 2023-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $214.50 | 2021-2025 | Winlevi |
| Regeneron Healthcare Solutions, INC. | $200.82 | 2022-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $171.13 | 2021-2022 | |
| Pfizer INC. | $106.79 | 2021-2025 | |
| Journey Medical Corporation | $73.06 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $61.91 | 2025 | Zoryve |
| Leo Pharma INC. | $57.91 | 2021-2022 | |
| Ucb, INC. | $57.25 | 2025 | Bimzelx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $52.67 | 2025 | Otezla |
| Botanix Sb INC | $47.77 | 2025 | Sofdra |
| Galderma Laboratories, L.P. | $38.64 | 2022 | |
| Boston Scientific Corporation | $16.77 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryam Ahmadian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.